IL-1β stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-κB

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 284, Issue 5 53-5, 2003, Pages

  Luo, Guangjo ^a,b   Hershko, Dan D ^a,b   Robb, Bruce W ^a,b   Wray, Curtis J ^a,b   Hasselgren, Per Olof ^c,d  

^a UNIVERSITY OF CINCINNATI   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cytokines; Interleukin 6 production; Mitogen activated protein kinase; Nuclear factor B

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN P44; SB 208350; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; ENZYME INHIBITOR; FLAVONOID; INTERLEUKIN 1;

ANIMAL CELL; ARTICLE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE CONSTRUCT; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOSTIMULATION; MOUSE; MUSCLE FIBER CULTURE; MYOTUBE; NONHUMAN; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; QUANTITATIVE ANALYSIS; RECOMBINANT PLASMID; REGULATORY MECHANISM; REPORTER GENE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; BIOSYNTHESIS; CELL LINE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; TIME;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLAVONOIDS; INTERLEUKIN-1; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SKELETAL; NF-KAPPA B; TIME FACTORS;

EID: 18244421931     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00490.2002     Document Type: Article

References (39)

1. Austin L, Bower J, Kurek J, and Vakakis N. Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. J Neurol Sci 112: 185-191, 1992.
2. Baron P, Galimberti D, Meda L, Scarpini E, Conti G, Cogiamanian F, and Scarlato G. Production of IL-6 by human myoblasts stimulated with Abeta: relevance in the pathogenesis of IBM. Neurology 57: 1561-1565, 2001.
3. Biondillo DE, Konicek SA, and Iwamoto GK. Interferon-γ regulation of interleukin 6 in monocytic cells. Am J Physiol Cell Physiol 267: C564-C568, 1994.
4. Cannon JG, Fielding RA, Fiatarone MA, Orencole SF, Dinarello CA, and Evans WJ. Increased interleukin 1β in human skeletal muscle after exercise. Am J Physiol Regul Integr Comp Physiol 257: R451-R455, 1989.
5. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
6. Craig R, Larkin A, Mingo AM, Thuerauf DJ, Andrews C, McDonough PM, and Glembotski CC. p38 MAPK and NF-κB collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem 275: 23814-23824, 2000.
7. De Rossi M, Bernasconi P, Baggi F, de Waal Malefyt R, and Mantegazza R. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol 12: 1329-1335, 2000.
8. Eickelberg O, Pansky A, Mussmann R, Bihl M, Tamm M, Hildebrand P, Perruchoud AP, and Roth M. Transforming growth factor-1β induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. J Biol Chem 274: 12933-12938, 1999.
9. Elias JA and Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol 145: 161-166, 1990.
10. Garcia-Martinez C, Lopez-Soriano FJ, and Argiles JM. Interleukin-6 does not activate protein breakdown in rat skeletal muscle. Cancer Lett 76: 1-4, 1994.
11. Ghosh S, May MJ, and Kopp EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260, 1998.
12. Helgren ME, Squinto SP, Davis HL, Parry DJ, Boulton TG, Heck CS, Zhu Y, Yancopoulos GD, Lindsay RM, and Di-Stefano PS. Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle. Cell 76: 493-504, 1994.
13. Hungness ES, Pritts TA, Luo GJ, Hershko DD, Robb BW, and Hasselgren PO. IL-1β activates C/EBP-β and C/EBP-δ in human enterocytes through a mitogen-activated protein-kinase signaling pathway. Int J Biochem Cell Biol 34: 382-395, 2002.
14. Jonsdottir IH, Schjerling P, Ostrowski K, Asp S, Richter EA, and Pedersen BK. Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles. J Physiol 528: 157-163, 2000.
15. Khan I, Blennerhassett MG, Kataeva GV, and Collins SM. Interleukin 1β induces the expression of interleukin 6 in rat intestinal smooth muscle cells. Gastroenterology 108: 1720-1728, 1995.
16. Kurek JB, Austin L, Cheema SS, Bartlett PF, and Murphy M. Upregulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and muscle following denervation. Neuromuscul Disord 6: 105-114, 1996.
17. Kurek JB, Nouri S, Kannourakis G, Murphy M, and Austin L. Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle Nerve 19: 1291-1301, 1996.
18. McGee DW, Beagley KW, Aicher WK, and McGhee JR. Transforming growth factor-β and IL-1β act in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6. J Immunol 151: 970-973, 1993.
19. Papanicolaou DA, Wilder RL, Manolagas SC, and Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. NIH Conference. Ann Intern Med 128: 127-137, 1998.
20. Parikh AA, Salzman AL, Fischer JE, Szabo C, and Hasselgren PO. Interleukin-10 and interferon-γ regulate interleukin-6 production in cultured human intestinal epithelial cells. Shock 8: 249-255, 1997.
21. Pedersen BK, Steensberg A, Fischer C, Keller C, Ostrowski K, and Schjerling P. Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev 7: 18-31, 2001.
22. Pedersen BK, Steensberg A, and Schjerling P. Muscle-derived interleukin-6: possible biological effects. J Physiol 536: 329-337, 2001.
23. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, and Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103: 565-575, 1993.
24. Pritts TA, Hungness ES, Hershko DD, Robb BW, Sun X, Luo GJ, Fischer JE, Wong HR, and Hasselgren PO. Proteasome inhibitors induce heat shock response and increase IL-6 expression in human intestinal epithelial cells. Am J Physiol Regul Integr Comp Physiol 282: R1016-R1026, 2002.
25. Pritts TA, Wang Q, Sun X, Moon RM, Fischer DR, Fischer JE, Wong HR, and Hasselgren PO. Induction of the stress response in vivo decreases nuclear factor-κB activity in jejunal mucosa of endotoxemic mice. Arch Surg 135: 860-866, 2000.
26. Saltzman AL, Dennenberg AG, Ueta I, O'Connor M, Linn SC, and Szabo C. Induction and activity of nitric oxide synthase in cultured human intestinal epithelial cell monolayers. Am J Physiol Gastrointest Liver Physiol 270: G565-G573, 1996.
27. Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, and Pedersen BK. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 537: 633-639, 2001.
28. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, and Pedersen B. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529: 237-242, 2000.
29. Strassmann G, Fong M, Kenney JS, and Jacob CO. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89: 1681-1684, 1992.
30. Suzuki K, Hino M, Kutsuna H, Hato F, Sakamoto C, Takahashi T, Tatsumi N, and Kitagawa S. Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1β. J Immunol 15: 5940-5947, 2001.
31. Testa M, De Ruvo E, Russo A, Citterio F, Serino F, Mangoni A, Capogrossi MC, and Sperti G. Induction of interleukin-1β and interleukin-6 gene expression in hypoperfused skeletal muscle of patients with peripheral arterial disease. Ital Heart J 1: 64-67, 2000.
32. Tsujinaka T, Ebisui C, Fujita J, Kishibuchi M, Morimoto T, Ogawa A, Katsume A, Ohsugi Y, Kominami E, and Monden M. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem Biophys Res Commun 207: 168-174, 1995.
33. Vanden Berghe W, De Bosscher K, Boone E, Plaisance S, and Haegeman G. The nuclear factor-κB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem 274: 32091-32098, 1999.
34. Vanden Berghe W, Vermeulen L, De Wilde G, De Bosscher K, Boone E, and Haegeman G. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem Pharmacol 60: 1185-1195, 2000.
35. Williams A, Wang JJ, Wang L, Sun X, Fischer JE, and Hasselgren PO. Sepsis in mice stimulates muscle proteolysis in the absence of IL-6. Am J Physiol Regul Integr Comp Physiol 275: R1983-R1991, 1998.
36. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, and Achong MK. IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101: 311-320, 1998.
37. Yaffe D and Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727, 1977.
38. Yassin MM, Harkin DW, Barros D'Sa AA, Halliday MI, and Rowlands BJ. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg 26: 115-121, 2002.
39. Yoshida N, Ikemoto S, Narita K, Sugimura K, Wada S, Yasumoto R, Kishimoto T, and Nakatani T. Interleukin-6, tumor necrosis factor-α and interleukin-1β in patients with renal cell carcinoma. Br J Cancer 6: 1396-1400, 2002.